{
    "organizations": [],
    "uuid": "304d89f377d7d66b6b6e0c5f32ffb1b5952936ba",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-corbus-pharmaceuticals-receives-25/brief-corbus-pharmaceuticals-receives-25-mln-development-award-from-the-cystic-fibrosis-foundation-idUSFWN1PP110",
    "ord_in_thread": 0,
    "title": "BRIEF-Corbus Pharmaceuticals Receives $25 Mln Development Award From The Cystic Fibrosis Foundation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Corbus Pharmaceuticals Holdings Inc :\n* CORBUS PHARMACEUTICALS RECEIVES $25 MILLION DEVELOPMENT AWARD FROM THE CYSTIC FIBROSIS FOUNDATION TO SUPPORT PHASE 2B CLINICAL STUDY OF LENABASUM Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-30T20:12:00.000+02:00",
    "crawled": "2018-01-31T16:43:14.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "corbus",
        "pharmaceutical",
        "holding",
        "inc",
        "corbus",
        "pharmaceutical",
        "receives",
        "million",
        "development",
        "award",
        "cystic",
        "fibrosis",
        "foundation",
        "support",
        "phase",
        "2b",
        "clinical",
        "study",
        "lenabasum",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}